Kazuo Imai

4.6k total citations · 1 hit paper
174 papers, 2.9k citations indexed

About

Kazuo Imai is a scholar working on Electrical and Electronic Engineering, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kazuo Imai has authored 174 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Electrical and Electronic Engineering, 27 papers in Infectious Diseases and 24 papers in Epidemiology. Recurrent topics in Kazuo Imai's work include Semiconductor materials and devices (51 papers), Advancements in Semiconductor Devices and Circuit Design (37 papers) and Radio Frequency Integrated Circuit Design (16 papers). Kazuo Imai is often cited by papers focused on Semiconductor materials and devices (51 papers), Advancements in Semiconductor Devices and Circuit Design (37 papers) and Radio Frequency Integrated Circuit Design (16 papers). Kazuo Imai collaborates with scholars based in Japan, United States and Thailand. Kazuo Imai's co-authors include Kazuyasu Miyoshi, Takuya Maeda, Shigefumi Maesaki, Norihito Tarumoto, Kaku Tamura, Toshimitsu Ito, Sakiko Tabata, Jun Sakai, M. Kourogi and Motoichi Ohtsu and has published in prestigious journals such as Nature Communications, Journal of Applied Physics and Journal of The Electrochemical Society.

In The Last Decade

Kazuo Imai

156 papers receiving 2.8k citations

Hit Papers

SARS-CoV-2 D614G spike mutation increases entry efficienc... 2021 2026 2022 2024 2021 100 200 300

Peers

Kazuo Imai
P. H. Yap Singapore
Yong Shin South Korea
Paul Southern United States
Kevin Killeen United States
Chris Webb United States
Anders Wolff Denmark
Kazuo Imai
Citations per year, relative to Kazuo Imai Kazuo Imai (= 1×) peers Hui‐Wen Chen

Countries citing papers authored by Kazuo Imai

Since Specialization
Citations

This map shows the geographic impact of Kazuo Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Imai more than expected).

Fields of papers citing papers by Kazuo Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Imai. The network helps show where Kazuo Imai may publish in the future.

Co-authorship network of co-authors of Kazuo Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Imai. A scholar is included among the top collaborators of Kazuo Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Imai. Kazuo Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tarumoto, Norihito, et al.. (2024). Multicenter Study of the Effectiveness of Antifungal Stewardship Team Intervention for Candidemia in Japan in 2008–2021. Infectious Disease Reports. 16(2). 356–366. 1 indexed citations
2.
Koshkin, Vadim S., Pongwut Danchaivijitr, Woo Kyun Bae, et al.. (2023). 2378P Efficacy and safety outcomes with pembrolizumab (pembro) rechallenge for patients (pts) with advanced/metastatic urothelial cancer (UC) who responded to first-course treatment. Annals of Oncology. 34. S1211–S1211. 2 indexed citations
3.
Balar, Arjun Vasant, Daniel Castellano, Petros Grivas, et al.. (2022). Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up. Annals of Oncology. 34(3). 289–299. 65 indexed citations
4.
Imai, Kazuo, Katsumi Kubota, Yutaro Kitagawa, et al.. (2021). Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan. Journal of Medical Microbiology. 70(4). 4 indexed citations
5.
Alva, Ajjai, Tibor Csőszi, Mustafa Özgüroğlu, et al.. (2020). LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361. Annals of Oncology. 31. S1155–S1155. 47 indexed citations
6.
Imai, Kazuo, Takashi Murakami, Yuji Fujikura, et al.. (2020). Optimization and evaluation of the ARCHITECT Chagas assay and in-house ELISA for Chagas disease in clinical settings in Japan. Parasitology International. 80. 102221–102221. 3 indexed citations
7.
Tarumoto, Norihito, Kazuo Imai, Jun Sakai, et al.. (2020). Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe. 64. 102215–102215. 13 indexed citations
8.
Imai, Kazuo, Sakiko Tabata, Mayu Ikeda, et al.. (2020). Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. Journal of Clinical Virology. 128. 104393–104393. 82 indexed citations
9.
Tabata, Sakiko, Kazuo Imai, Shuichi Kawano, et al.. (2020). Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis. The Lancet Infectious Diseases. 20(9). 1043–1050. 170 indexed citations
10.
Imai, Kazuo, Noriomi Ishibashi, Norihito Tarumoto, et al.. (2019). Clinical characteristics in blood stream infections caused by Klebsiella pneumoniae, Klebsiella variicola, and Klebsiella quasipneumoniae: a comparative study, Japan, 2014–2017. BMC Infectious Diseases. 19(1). 946–946. 56 indexed citations
11.
Imai, Kazuo, Norihito Tarumoto, Jun Sakai, et al.. (2019). Endogenous endophthalmitis secondary to septic arthritis caused by group A Streptococcus infection: A case report and literature review. Journal of Infection and Chemotherapy. 26(1). 128–131. 4 indexed citations
12.
Tarumoto, Norihito, Noriyuki Watanabe, Jun Sakai, et al.. (2018). First report of the isolation of blaIMI-1-producing colistin-heteroresistant Enterobacter cloacae in Japan, September 2016. Journal of Infection and Chemotherapy. 24(11). 941–943. 10 indexed citations
13.
Tamura, Shinsuke, Takuya Maeda, Atsushi Yuki, et al.. (2017). Development of a highly resolved loop-mediated isothermal amplification method to detect the N526K ftsI mutation of β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Journal of Microbiological Methods. 141. 108–114. 19 indexed citations
14.
Maeda, Takuya, et al.. (2016). Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman's disease in an HIV-positive patient. Journal of Infection and Chemotherapy. 22(12). 804–807.
16.
Kimizuka, N., T. Yamamoto, Tohru Mogami, et al.. (1999). The impact of bias temperature instability for direct-tunneling ultra-thin gate oxide on MOSFET scaling. 73–74. 165 indexed citations
17.
Murata, Takuya, et al.. (1994). Portable Digital Satellite News Gathering (SNG) RF Terminal Using a Flat Antenna. IEICE Transactions on Communications. 95(12). 1501–1510.
18.
Imai, Kazuo, et al.. (1991). A 42-GHz-band low-noise downconverter. IEICE Transactions on Fundamentals of Electronics Communications and Computer Sciences. 74(12). 4124–4130. 5 indexed citations
19.
Imai, Kazuo, et al.. (1985). IMPROVED D50 CIRCUIT SWITCHING EQUIPMENT.. 33(6). 931–938. 1 indexed citations
20.
Imai, Kazuo & S. Nakajima. (1981). Full isolation technology by porous oxidized silicon and its application to LSIs. 376–379. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026